stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. ONTTF
    stockgist
    HomeTop MoversCompaniesConcepts
    ONTTF logo

    Oxford Nanopore Technologies plc

    ONTTF
    OTC
    Healthcare
    Biotechnology
    Oxford, GB1,382 employeesnanoporetech.com
    —

    At A Glance

    1

    Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees1,382
    Fundamentals

    How The Business Makes Money

    Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.

    Industry Biotechnology
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    ZRSEFDocMorris AG————
    PHMMFPharma Mar, S.A.————
    GENSFGenus plc————
    BRCTFBioArctic AB (publ)————
    PPTDFPeptiDream Inc.————
    SZUKFSuzuken Co., Ltd.————
    MEOBFMesoblast Limited————
    CSPHFCStone Pharmaceuticals————
    Analyst View
    Company Profile
    CIKUNKNOWN_ONTTF
    ISINGB00BP6S8Z30
    Phone44 84 5034 7900
    AddressGosling Building, Oxford, OX4 4DQ, GB
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice